A buyer guide to longevity medicine implementation: how to judge clinic delivery, governance, AI claims, incidental findings, and follow-up before you pay.
A practical guide to the follow-up plan after a longevity assessment: clinical ownership, abnormal findings, referrals, retesting, records, costs, and red flags.
A buyer scorecard for separating completed tests, biomarker changes, functional progress, patient-important outcomes, safety, and unresolved follow-up.
A buyer-focused guide to epigenetic testing at longevity clinics: when biological-age clocks add useful context, when they become sales theater, and what to ask before paying.
A provider-neutral 100-point scorecard for evaluating licensing, evidence, diagnostics, follow-up, pricing and records before paying a longevity clinic.
